SBDM 08
Alternative Names: SBDM-08Latest Information Update: 29 Jan 2025
Price :
$50 *
At a glance
- Originator Shilpa Biologicals
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Colorectal cancer; Lung cancer
Highest Development Phases
- Research Colorectal cancer; Lung cancer
Most Recent Events
- 05 Aug 2024 SBDM 08 is available for licensing as of 05 Aug 2024. https://www.shilpabio.com/partnerships/
- 05 Aug 2024 Early research in Colorectal cancer in India (unspecified route), prior to August 2024 (Shilpa Biologicals pipeline, December 2024)
- 05 Aug 2024 Early research in Lung cancer in India (unspecified route), prior to August 2024 (Shilpa Biologicals pipeline, December 2024)